Warfarin Treatment Duration Linked to Risk for Recurrent VTE

MedWire News -- Warfarin discontinuation within 3 months of a thromboembolic event is associated with a higher rate of recurrent venous thromboembolism (VTE) than warfarin continuation, a US population-based study has shown.